NCT06866600 - IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Heart FailureHeart Failure At NYHA Stage III or IV

Interventions

BIOLOGICAL

low dose CABG+iPSC-CMs

CABG+0.5×10\^8 iPSC-CMs

BIOLOGICAL

High dose CABG/LVAD+iPSC-CMs

CABG+1.5×10\^8 iPSC-CMs or LVAD+1.5×10\^8 iPSC-CMs

OTHER

CABG/LVAD+Saline

Trial Locations (1)

HelpThera, Nanjing